Vitamin Shoppe (VSI) Trading Up 7% After Insider Buying Activity

Vitamin Shoppe Inc (NYSE:VSI) shares were up 7% during trading on Thursday following insider buying activity. The company traded as high as $4.65 and last traded at $4.60. Approximately 823,301 shares changed hands during mid-day trading, an increase of 31% from the average daily volume of 630,467 shares. The stock had previously closed at $4.30.

Specifically, major shareholder Vintage Capital Management Llc acquired 133,804 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The stock was acquired at an average cost of $4.28 per share, for a total transaction of $572,681.12. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.07% of the stock is owned by corporate insiders.

A number of equities analysts recently issued reports on VSI shares. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. Morgan Stanley decreased their price target on shares of Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating for the company in a research report on Thursday, November 9th. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Finally, Barclays decreased their price target on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a research report on Thursday, November 9th. Four equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $5.00.

The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. The stock has a market cap of $110.30, a PE ratio of -0.43 and a beta of 0.68.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The business had revenue of $288.20 million during the quarter, compared to analyst estimates of $297.61 million. During the same quarter last year, the company posted $0.50 earnings per share. The company’s revenue was down 8.5% compared to the same quarter last year. equities analysts predict that Vitamin Shoppe Inc will post 0.34 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently made changes to their positions in the business. BNP Paribas Arbitrage SA boosted its stake in shares of Vitamin Shoppe by 2.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after purchasing an additional 192 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in shares of Vitamin Shoppe by 18.1% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after purchasing an additional 1,440 shares during the last quarter. Wolverine Trading LLC bought a new stake in shares of Vitamin Shoppe in the 2nd quarter valued at $131,000. UBS Asset Management Americas Inc. boosted its stake in shares of Vitamin Shoppe by 17,041.4% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in shares of Vitamin Shoppe by 0.8% in the 2nd quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock valued at $145,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 90.35% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://transcriptdaily.com/2018/01/05/vitamin-shoppe-vsi-trading-up-7-after-insider-buying-activity.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply